Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Nuance Communications Inc. (NUAN), SUPERVALU INC. (SVU): Hedge Funds Are Buying These Stocks

Adage Capital Management reported a position of a little over 4 million shares in Medivation Inc (NASDAQ:MDVN), the developer of prostate cancer drug Xtandi. Research more stocks Adage has been buying. Xtandi has only recently started being marketed, and Medivation is researching other channels for using the drug against cancer. The company is currently unprofitable, though analyst consensus is for earnings per share of 41 cents in 2014. Medivation used $100 million of cash on operations in 2012, but the company has about $300 million in cash, cash equivalents, and short term investments so cash should not be a problem for now.

Brian Taylor and the team at Pine River Capital Management were bullish on Anworth Mortgage Asset Corporation (NYSE:ANH), owning 9.1 million shares (or 6.4% of the outstanding shares) according to a filing. Anworth is a real estate investment trust investing in mortgage-backed and other real estate securities. Real estate investment trusts are required to distribute a large share of their taxable income to shareholders in order to preserve their favorable tax status; this often results in high dividend yields, and Anworth’s yield is currently over 9%. We would note that dividend payments have been showing a downward trend the last few years.

Disclosure: I own no shares of any stocks mentioned in this article.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.